Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 32

1.

Poly-ADP-ribose polymerase inhibitor use in ovarian cancer: expanding indications and novel combination strategies.

Hinchcliff E, Westin SN, Dal Molin G, LaFargue CJ, Coleman RL.

Int J Gynecol Cancer. 2019 May 22. pii: ijgc-2019-000499. doi: 10.1136/ijgc-2019-000499. [Epub ahead of print]

PMID:
31118216
2.

Exploring and comparing adverse events between PARP inhibitors.

LaFargue CJ, Dal Molin GZ, Sood AK, Coleman RL.

Lancet Oncol. 2019 Jan;20(1):e15-e28. doi: 10.1016/S1470-2045(18)30786-1. Review.

PMID:
30614472
3.

Predicting Novel Therapies and Targets: Regulation of Notch3 by the Bromodomain Protein BRD4.

Villar-Prados A, Wu SY, Court KA, Ma S, LaFargue C, Chowdhury MA, Engelhardt MI, Ivan C, Ram PT, Wang Y, Baggerly K, Rodriguez-Aguayo C, Lopez-Berestein G, Ming-Yang S, Maloney DJ, Yoshioka M, Strovel JW, Roszik J, Sood AK.

Mol Cancer Ther. 2019 Feb;18(2):421-436. doi: 10.1158/1535-7163.MCT-18-0365. Epub 2018 Nov 12.

PMID:
30420565
4.

When Ovarian Cancer Is Not: Characterizing Nonovarian Cancer Pathology in a Laparoscopy-Based Triage System.

Dood RL, Fleming ND, Coleman RL, Westin SN, Lara OD, LaFargue CJ, Liu J, Sood AK.

Int J Gynecol Cancer. 2018 Oct;28(8):1485-1490. doi: 10.1097/IGC.0000000000001329.

5.

ADH1B promotes mesothelial clearance and ovarian cancer infiltration.

Gharpure KM, Lara OD, Wen Y, Pradeep S, LaFargue C, Ivan C, Rupaimoole R, Hu W, Mangala LS, Wu SY, Nagaraja AS, Baggerly K, Sood AK.

Oncotarget. 2018 May 18;9(38):25115-25126. doi: 10.18632/oncotarget.25344. eCollection 2018 May 18.

6.

Strong Electro-Optic Effect and Spontaneous Domain Formation in Self-Assembled Peptide Structures.

Gilboa B, Lafargue C, Handelman A, Shimon LJW, Rosenman G, Zyss J, Ellenbogen T.

Adv Sci (Weinh). 2017 May 11;4(9):1700052. doi: 10.1002/advs.201700052. eCollection 2017 Sep.

7.

Short-term morbidity in transdiaphragmatic cardiophrenic lymph node resection for advanced stage gynecologic cancer.

LaFargue CJ, Sawyer BT, Bristow RE.

Gynecol Oncol Rep. 2016 May 24;17:33-7. doi: 10.1016/j.gore.2016.05.006. eCollection 2016 Aug.

8.

Extended left upper quadrant resection during primary cytoreductive surgery for Stage IV ovarian cancer.

Sawyer BT, LaFargue CJ, Bristow RE.

Gynecol Oncol. 2016 Aug;142(2):378. doi: 10.1016/j.ygyno.2016.06.001. Epub 2016 Jun 6.

PMID:
27264212
9.

Recent Patents for Homologous Recombination Deficiency Assays Among Women with Ovarian Cancer.

LaFargue CJ, Tewari KS.

Recent Pat Biotechnol. 2016;9(2):86-101. Review.

PMID:
26961668
10.

Second harmonic generation from gold meta-molecules with three-fold symmetry.

Hou R, Shynkar V, Lafargue C, Kolkowski R, Zyss J, Lagugné-Labarthet F.

Phys Chem Chem Phys. 2016 Mar 21;18(11):7956-65. doi: 10.1039/c6cp00154h.

PMID:
26956914
11.

Transdiaphragmatic cardiophrenic lymph node resection for Stage IV ovarian cancer.

LaFargue CJ, Bristow RE.

Gynecol Oncol. 2015 Sep;138(3):762-3. doi: 10.1016/j.ygyno.2015.06.002. Epub 2015 Jun 3. No abstract available.

PMID:
26049122
12.

Localized lasing modes of triangular organic microlasers.

Lafargue C, Lebental M, Grigis A, Ulysse C, Gozhyk I, Djellali N, Zyss J, Bittner S.

Phys Rev E Stat Nonlin Soft Matter Phys. 2014 Nov;90(5-1):052922. Epub 2014 Nov 25.

PMID:
25493873
13.

Routine cystoscopy after robotic gynecologic oncology surgery.

Nguyen ML, Stevens E, LaFargue CJ, Karsy M, Pua TL, Gorelick C, Tedjarati SS, Pradhan TS.

JSLS. 2014 Jul-Sep;18(3). pii: e2014.00261. doi: 10.4293/JSLS.2014.00261.

14.

Three-dimensional organic microlasers with low lasing thresholds fabricated by multiphoton and UV lithography.

Chen VW, Sobeshchuk N, Lafargue C, Mansfield ES, Yom J, Johnstone LR, Hales JM, Bittner S, Charpignon S, Ulbricht D, Lautru J, Denisyuk I, Zyss J, Perry JW, Lebental M.

Opt Express. 2014 May 19;22(10):12316-26. doi: 10.1364/OE.22.012316.

PMID:
24921350
15.

Grade 1 endometrioid endometrial carcinoma presenting with pelvic bone metastasis: a case report and review of the literature.

Nguyen ML, Lafargue CJ, Pua TL, Tedjarati SS.

Case Rep Obstet Gynecol. 2013;2013:807205. doi: 10.1155/2013/807205. Epub 2013 Apr 22.

16.

ERG cooperates with androgen receptor in regulating trefoil factor 3 in prostate cancer disease progression.

Rickman DS, Chen YB, Banerjee S, Pan Y, Yu J, Vuong T, Perner S, Lafargue CJ, Mertz KD, Setlur SR, Sircar K, Chinnaiyan AM, Bismar TA, Rubin MA, Demichelis F.

Neoplasia. 2010 Dec;12(12):1031-40.

17.

Testing mutual exclusivity of ETS rearranged prostate cancer.

Svensson MA, LaFargue CJ, MacDonald TY, Pflueger D, Kitabayashi N, Santa-Cruz AM, Garsha KE, Sathyanarayana UG, Riley JP, Yun CS, Nagy D, Kosmeder JW, Pestano GA, Tewari AK, Demichelis F, Rubin MA.

Lab Invest. 2011 Mar;91(3):404-12. doi: 10.1038/labinvest.2010.179. Epub 2010 Oct 25.

18.

TMPRSS2-ERG gene fusion prevalence and class are significantly different in prostate cancer of Caucasian, African-American and Japanese patients.

Magi-Galluzzi C, Tsusuki T, Elson P, Simmerman K, LaFargue C, Esgueva R, Klein E, Rubin MA, Zhou M.

Prostate. 2011 Apr;71(5):489-97. doi: 10.1002/pros.21265. Epub 2010 Sep 28.

PMID:
20878952
19.

Rearrangements of the RAF kinase pathway in prostate cancer, gastric cancer and melanoma.

Palanisamy N, Ateeq B, Kalyana-Sundaram S, Pflueger D, Ramnarayanan K, Shankar S, Han B, Cao Q, Cao X, Suleman K, Kumar-Sinha C, Dhanasekaran SM, Chen YB, Esgueva R, Banerjee S, LaFargue CJ, Siddiqui J, Demichelis F, Moeller P, Bismar TA, Kuefer R, Fullen DR, Johnson TM, Greenson JK, Giordano TJ, Tan P, Tomlins SA, Varambally S, Rubin MA, Maher CA, Chinnaiyan AM.

Nat Med. 2010 Jul;16(7):793-8. doi: 10.1038/nm.2166. Epub 2010 Jun 6.

20.

SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas.

Bass AJ, Watanabe H, Mermel CH, Yu S, Perner S, Verhaak RG, Kim SY, Wardwell L, Tamayo P, Gat-Viks I, Ramos AH, Woo MS, Weir BA, Getz G, Beroukhim R, O'Kelly M, Dutt A, Rozenblatt-Rosen O, Dziunycz P, Komisarof J, Chirieac LR, Lafargue CJ, Scheble V, Wilbertz T, Ma C, Rao S, Nakagawa H, Stairs DB, Lin L, Giordano TJ, Wagner P, Minna JD, Gazdar AF, Zhu CQ, Brose MS, Cecconello I, Ribeiro U Jr, Marie SK, Dahl O, Shivdasani RA, Tsao MS, Rubin MA, Wong KK, Regev A, Hahn WC, Beer DG, Rustgi AK, Meyerson M.

Nat Genet. 2009 Nov;41(11):1238-42. doi: 10.1038/ng.465. Epub 2009 Oct 4.

21.

In situ evidence of KRAS amplification and association with increased p21 levels in non-small cell lung carcinoma.

Wagner PL, Perner S, Rickman DS, LaFargue CJ, Kitabayashi N, Johnstone SF, Weir BA, Meyerson M, Altorki NK, Rubin MA.

Am J Clin Pathol. 2009 Oct;132(4):500-5. doi: 10.1309/AJCPF10ZUNSOLIFG.

PMID:
19762526
22.

Amplification of chromosomal segment 4q12 in non-small cell lung cancer.

Ramos AH, Dutt A, Mermel C, Perner S, Cho J, Lafargue CJ, Johnson LA, Stiedl AC, Tanaka KE, Bass AJ, Barretina J, Weir BA, Beroukhim R, Thomas RK, Minna JD, Chirieac LR, Lindeman NI, Giordano T, Beer DG, Wagner P, Wistuba II, Rubin MA, Meyerson M.

Cancer Biol Ther. 2009 Nov;8(21):2042-50. Epub 2009 Nov 7.

23.

N-myc downstream regulated gene 1 (NDRG1) is fused to ERG in prostate cancer.

Pflueger D, Rickman DS, Sboner A, Perner S, LaFargue CJ, Svensson MA, Moss BJ, Kitabayashi N, Pan Y, de la Taille A, Kuefer R, Tewari AK, Demichelis F, Chee MS, Gerstein MB, Rubin MA.

Neoplasia. 2009 Aug;11(8):804-11.

24.

Oncosome formation in prostate cancer: association with a region of frequent chromosomal deletion in metastatic disease.

Di Vizio D, Kim J, Hager MH, Morello M, Yang W, Lafargue CJ, True LD, Rubin MA, Adam RM, Beroukhim R, Demichelis F, Freeman MR.

Cancer Res. 2009 Jul 1;69(13):5601-9. doi: 10.1158/0008-5472.CAN-08-3860. Epub 2009 Jun 23.

25.

Distinct genomic aberrations associated with ERG rearranged prostate cancer.

Demichelis F, Setlur SR, Beroukhim R, Perner S, Korbel JO, Lafargue CJ, Pflueger D, Pina C, Hofer MD, Sboner A, Svensson MA, Rickman DS, Urban A, Snyder M, Meyerson M, Lee C, Gerstein MB, Kuefer R, Rubin MA.

Genes Chromosomes Cancer. 2009 Apr;48(4):366-80. doi: 10.1002/gcc.20647.

26.

TMPRSS2-ERG fusion is frequently observed in Gleason pattern 3 prostate cancer in a Canadian cohort.

Darnel AD, Lafargue CJ, Vollmer RT, Corcos J, Bismar TA.

Cancer Biol Ther. 2009 Jan;8(2):125-30. Epub 2009 Feb 4.

PMID:
19029822
27.

TTF1 expression in non-small cell lung carcinoma: association with TTF1 gene amplification and improved survival.

Perner S, Wagner PL, Soltermann A, LaFargue C, Tischler V, Weir BA, Weder W, Meyerson M, Giordano TJ, Moch H, Rubin MA.

J Pathol. 2009 Jan;217(1):65-72. doi: 10.1002/path.2443.

28.

EML4-ALK fusion lung cancer: a rare acquired event.

Perner S, Wagner PL, Demichelis F, Mehra R, Lafargue CJ, Moss BJ, Arbogast S, Soltermann A, Weder W, Giordano TJ, Beer DG, Rickman DS, Chinnaiyan AM, Moch H, Rubin MA.

Neoplasia. 2008 Mar;10(3):298-302.

29.

The human ATP binding cassette gene ABCA13, located on chromosome 7p12.3, encodes a 5058 amino acid protein with an extracellular domain encoded in part by a 4.8-kb conserved exon.

Prades C, Arnould I, Annilo T, Shulenin S, Chen ZQ, Orosco L, Triunfol M, Devaud C, Maintoux-Larois C, Lafargue C, Lemoine C, Denèfle P, Rosier M, Dean M.

Cytogenet Genome Res. 2002;98(2-3):160-8.

PMID:
12697998
30.

Comparative analysis of the promoter structure and genomic organization of the human and mouse ABCA7 gene encoding a novel ABCA transporter.

Broccardo C, Osorio J, Luciani MF, Schriml LM, Prades C, Shulenin S, Arnould I, Naudin L, Lafargue C, Rosier M, Jordan B, Mattei MG, Dean M, Denèfle P, Chimini G.

Cytogenet Cell Genet. 2001;92(3-4):264-70.

PMID:
11435699
31.

No evidence for involvement of KCNN3 (hSKCa3) potassium channel gene in familial and isolated cases of schizophrenia.

Bonnet-Brilhault F, Laurent C, Campion D, Thibaut F, Lafargue C, Charbonnier F, Deleuze JF, Ménard JF, Jay M, Petit M, Frebourg T, Mallet J.

Eur J Hum Genet. 1999 Feb-Mar;7(2):247-50.

32.

Detection of two new polymorphic sites in the human interleukin-1 beta gene: lack of association with schizophrenia in a French population.

Laurent C, Thibaut F, Ravassard P, Campion D, Samolyk D, Lafargue C, Petit M, Martinez M, Mallet J.

Psychiatr Genet. 1997 Autumn;7(3):103-5.

PMID:
9323321

Supplemental Content

Loading ...
Support Center